Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION • Use of …
{{id}} {{{paragraph}}}
Example: stock market
HIGHLIGHTS OF PRESCRIBING INFORMATION • Use of …
1 HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese HIGHLIGHTS do not include all the INFORMATION needed to use cymbalta safely and effectively. See full PRESCRIBING INFORMATION for (Duloxetine Delayed-Release Capsules) for Oral Approval: 2004 WARNING: SUICIDALTHOUGHTSAND BEHAVIORSSee full PRESCRIBING INFORMATION for complete boxed warning. Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants ( ) Monitor for worsening and emergence of suicidal thoughts and behaviors ( )---------------------------RECENT MAJOR AND USAGE--------------------------- cymbalta is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: Major Depressive Disorder (MDD) (1) Generalized Anxiety Disorder (GAD) (1) Diabetic Peripheral Neuropathic Pain (DPNP) (1) Fibromyalgia (FM) (1) Chronic Musculoskeletal Pain (1)------------------------DOSAGE AND ADMINISTRATION----------------------- Take cymbalta o
• Hepatotoxicity: Hepatic failure, sometimes fatal, has been reported. Discontinue CYMBALTA in patients who develop jaundice or other evidence of clinically significant liver dysfunction and should not be resumed unless another cause can be established. Avoid use in patients with substantial alcohol use or evidence of chronic liver disease (5.2)
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: